跳至主要内容
临床试验/NCT07333222
NCT07333222招募中不适用

Prospective, Placebo-controlled Study on the Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis

Somogy Megyei Kaposi Mór Teaching Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
2
主要终点
Functional Independence Measure (FIM)

研究概览

简要总结

  • Objective assessment of clinical symptoms resulting from stroke, as well as changes in mobility and quality of life, and determination of changes resulting from therapies
  • Objective assessment of the quality of life, functionality, and clinical symptoms of patients with multiple sclerosis (MS) and determination of changes resulting from therapies
  • Comparison of measured data from the two main neurological patient groups (stroke, multiple sclerosis) and follow-up of changes in relation to themselves and each other.
  • Mapping the role of the placebo effect in neuromodulation devices by comparing subjective and objective outcomes.
  • Analyzing the expectations and experiences of patients receiving placebo treatment using quality of life questionnaires.
  • Analyzing the effects of the Mollii suit among subgroups of MS and stroke patients.
  • Assessing the safety, possible side effects, and tolerability of the Mollii suit.
  • Mapping changes in gait pattern due to the effects of therapy using 3D motion analysis.
  • Examining the maintenance effects of neuromodulation during a 1-month follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • suffered a first ischemic stroke, diagnosed by a neurologist based on CT or MR imaging
  • neurological examination revealed mobility and postural limitations
  • confirmed multiple sclerosis diagnosed by a neurologist based on MRI imaging

排除标准

  • multiple strokes in medical history
  • systolic blood pressure less than 120 or higher than 160 mmHg
  • orthostatic hypotension
  • arotid artery stenosis
  • severe heart disease
  • hemophilia
  • traumatic brain injury
  • seizure disorder
  • untreated diabetes
  • abnormal electroencephalography
  • abnormal blood panel
  • use of sedatives
  • irregular medication use
  • severe aphasia (Western Aphasia Battery ≤ 25)
  • severe visual or hearing impairment
  • severe sensory dysfunction
  • severe orthopedic problems
  • other neurological conditions affecting motor function
  • alcoholism
  • smoking after diagnosis of stroke
  • unable to walk at least 10 m with or without assistance in 6 minutes
  • BBS score ≤ 32
  • BI score ≤ 70
  • current participation in individual or group exercise program outside of standard physical therapy

研究组 & 干预措施

Mollii Group

Experimental

Receaving treatment with the stimulation program.

干预措施: the Mollii garment with active stimulation (Other)

Control Group

Placebo Comparator

Receaving treatment without the stimulation program.

干预措施: Mollii neuromodulation garment, but the stimulation program is not activated (placebo) (Other)

结局指标

主要结局

Functional Independence Measure (FIM)

时间窗: 4 weeks

Functional autonomy, scaling 18-126 points. The lower the score, the less self-sufficient the patient is.

Barthel Index (BI)

时间窗: 4 weeks

Everyday activities, scaling 0-100 points. The higher the score, the better the self-sufficiency.

次要结局

  • Stroke Impact Scale (SIS)(4 weeks)
  • Multiple Sclerosis Impact Scale (MSIS-29)(4 weeks)
  • Berg Balance Scale (BBS)(4 weeks)
  • Tinetti(4 weeks)
  • Timed Up and Go (TUG)(4 weeks)
  • 6 minute walk test (6MWT)(4 weeks)
  • 10 meter walk test (10mWT)(4 weeks)
  • Posturographic examination(4 weeks)
  • 3D motion analysis(4 weeks)

研究者

发起方
Somogy Megyei Kaposi Mór Teaching Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tollár József

Head of Department

Somogy Megyei Kaposi Mór Teaching Hospital

研究点 (2)

Loading locations...

相似试验